rivaroxaban
bayer
['invictus', 'rivaroxaban']
compared w/ rivaroxaban therapy, vka therapy in patients w rheumatic heart disease-associated #afib was associated w/ a lower rate of cv events or death &amp; no higher rate of bleeding, according to findings from the invictus trial presented at #esccongress. 
Official account of the American College of Cardiology. Join us to transform cardiovascular care & improve heart health. Find us: @JACCJournals @Cardiology